Type 2 diabetes (T2D), cardiovascular disease and chronic kidney disease (CKD) often occur together in individuals due to shared risk factors. General practitioners play a central role in T2D management, identifying those at risk and providing optimal management.
Reducing Cardiovascular and Renal Risk in Type 2 Diabetes – More than just Glycaemic Control – RACGP
Australie
$0
gratuit
RACGP CPD Accredited Activity
4.5 hrs
Endocrinology
40 Credits
Description du cours
Détails du cours
Date d'expiration : 2022-03-01
Métiers: Médecin
Faculté
Dr Gary Deed
MBBS, MRACGP
Professor Andrew Sindone
B. Med (Hons), MD, FRACP, FCSANZ, FNHFA
Dr Marwan Obaid
MBBS, BSc(Med), FRACP, MMed
Accréditation
This 4.5 hour interactive online learning activity is accredited by the Royal Australian College of General Practitioners for 40 points.
Activity no. 213312
Objectif(s) d'apprentissage
On completion of this program, participants will be able to:
- Describe the epidemiological and
pathophysiological relationship between heart failure, chronic kidney disease
and type-2 diabetes (T2D) - Evaluate the risk or presence of
cardiovascular and/or kidney disease when selecting treatment protocols for
managing glycaemia in T2D and glucose-independent mechanisms of disease - Implement appropriate management strategies
for patients with T2D according to current national and international
management guidelines - Consider treatments for T2D which reduce CV
and renal risk beyond glycaemic control - Consider
long-term patient wellbeing and safety regarding primary prevention of
cardiovascular disease when selecting diabetes medicines